Search Browse Earnings

BioAge Labs, Inc. — SlamSEC

BioAge Labs, Inc.

Nasdaq:BIOA

Pharmaceutical Preparations·EMERYVILLE, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$48.2M

FY 2024

Net Income

-$63.9M

FY 2024

EPS (Diluted)

-$38.17

FY 2024

Stock Price

$20.97

+3.4%

2026-03-10

52W Range

$2.88 – $24.00

P/E Ratio

-0.5x

Market Cap

$751.9M

Cash

$21.6M

FY 2024

Total Debt

$8.2M

FY 2024

Net Cash

$13.4M

FY 2024

Enterprise Value

$738.4M

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

-15.3x

Employees

—